Clinical trial
Usefulness of Markers to Predict Recurrence of Atrial Fibrillation After…
NCT00315068 · University Hospital, Geneva, Other · Unknown status
Key facts
| NCT number | NCT00315068 |
|---|---|
| Title | Usefulness of Markers to Predict Recurrence of Atrial Fibrillation After Radiofrequency Catheter Ablation |
| Official title | The Value of Amino-Terminal Brain Natriuretic Peptide and C-Reactive Protein Serum Levels for Predicting Recurrence of Atrial Fibrillation and/or Atrial Flutter After Radiofrequency Catheter Ablation |
| Lead sponsor | University Hospital, Geneva, Other |
| Status | Unknown status |
| Study type | Observational |
| Conditions | Atrial Fibrillation |
| Enrollment | 180 |
| Start date | Apr 1, 2004 |
| Completion | Aug 1, 2007 |
| First posted | Apr 17, 2006 |
| Last update posted | Apr 20, 2007 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: